The Harvard Drug Group LLC 2025-07-09 Health serious FDA
Health · FDA · Recall #FDA-D-0507-2025
Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only,… Recall
Issued July 9, 2025 · The Harvard Drug Group LLC
In July 2025, The Harvard Drug Group LLC recalled the Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective container; blister packaging inadequately sealed.
What you should do
- 1 Stop using Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact The Harvard Drug Group LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- The Harvard Drug Group LLC
- Category
- Health
- Recall date
- July 9, 2025
- Units affected
- Not reported
- Sold at
- Nationwide
- Recall number
- FDA-D-0507-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- The Harvard Drug Group LLC has 4 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.